Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC
Authors:
Open Access
- 17 August 2017
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 16 (1) , 1-10
Abstract
There is increasing evidence in support of the role of lncRNAs in tumor cell proliferation, differentiation and apoptosis. We examined the expression of the lncRNA ABHD11-AS1 in epithelial ovarian cancer (EOC) tissues and normal ovarian tissues by real-time quantitative PCR (qRT-PCR). After inducing ABHD11-AS1 downregulation by small interfering RNA (siRNA) or ABHD11-AS1 overexpression by plasmid transfection, we examined the EOC cell phenotypes and expression of related molecules. Expression of the lncRNA ABHD11-AS1 in EOC tissues was higher than that in normal ovarian tissue. It was positively associated with the tumor stage (stage I/II vs. stage III/IV), and it was lower in the well-differentiated group than in the poorly/moderately differentiated group. Overexpression of ABHD11-AS1 in the ovarian cancer cell lines A2780 and OVCAR3 promoted ovarian cancer cell proliferation, invasion and migration, and inhibited apoptosis. Silencing of ABHD11-AS1 had the opposite effect. Subcutaneous injection of tumor cells in nude mice showed that ABHD11-AS1 could significantly promote tumor growth. In addition, intraperitoneal injection of tumor cells in the nude mice resulted in an increase in the metastatic ability of the tumor. Further, overexpression of ABHD11-AS1 upregulated the expression of RhoC and its downstream molecules P70s6k, MMP2 and BCL-xL. Silencing of ABHD11-AS1 had the opposite effect. The RNA pull-down assay showed that ABHD11-AS1 can combine directly with RhoC. Silencing of RhoC was found to inhibit the cancer-promoting effects of lncRNA ABHD11-AS1. Thus, it seems that RhoC is a major target of the lncRNA ABHD11-AS1. This is the first study to demonstrate the role of RhoC in the tumor-promoting effects of the lncRNA ABHD11-AS1. The present findings shed light on new therapeutic targets for ovarian cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81472440)
This publication has 37 references indexed in Scilit:
- MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell linesBiochemical Journal, 2011
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- RhoC Expression and Head and Neck Cancer MetastasisMolecular Cancer Research, 2009
- Long noncoding RNAs: functional surprises from the RNA worldGenes & Development, 2009
- Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesisClinical & Experimental Metastasis, 2008
- RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and NeckClinical Cancer Research, 2006
- RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivoEuropean Journal of Cancer, 2006
- RHO GTPASES: Biochemistry and BiologyAnnual Review of Cell and Developmental Biology, 2005
- Tumor progression: Small GTPases and loss of cell–cell adhesionBioEssays, 2003